u/Murphus5

This article includes interesting information on GLP1 "super responders." Even though the link is from a online pharmacy, I'm not spamming. I get my Zepbound through Lilly Direct. I wanted to share the peer reviewed literature quoted. I'm an RN researching gene mutations, such as NBEA, and the estrogen connection with "super responders.

Nference & Mayo Clinic (2025). Decoding the hallmarks of GLP-1RA weight-loss super-responders: A real-world data analysis. https://www.medrxiv.org/content/10.1101/2025.11.15.25340314v1

Cleveland Clinic (2025). Research Finds Injectable Medications for Obesity Produce Smaller Weight Loss in A Real-World Setting. https://newsroom.clevelandclinic.org/2025/06/10/cleveland-clinic-research-finds-injectable-medications-for-obesity-produce-smaller-weight-loss-in-a-real-world-setting-compared-to-randomized-clinical-trials

Cleveland Clinic Newsroom (2025). Gene Could Impact Weight Loss Using GLP-1, Study Finds.https://newsroom.clevelandclinic.org/2025/09/23/gene-could-impact-weight-loss-using-glp-1-study-finds

Johns Hopkins Bloomberg School of Public Health (2026). GLP-1 Weight-Loss Drugs Comparably Effective for Patients Across Age, Race, and Starting Weight. https://publichealth.jhu.edu/2026/glp-1-weight-loss-drugs-comparably-effective-for-patients-across-age-race-and-starting-weight

JAMA Internal Medicine (2026). GLP-1 Weight-Loss Drugs Prove Effective Across Diverse Patient Groups.https://hub.jhu.edu/2026/03/03/glp-1-drugs-effective-across-demographics/

Johns Hopkins University (2025). Sex Differences in Obesity and Its Treatment.https://pure.johnshopkins.edu/en/publications/sex-differences-in-obesity-and-its-treatment/